Table 4. Hazard Ratios for 30-day All-Cause Mortality following VAD Implantation.

UNIVARIATE ANALYSIS	HR (95%CI)	P value
Age	1.04(0.99–1.09)	0.07
Male Sex	1.50(0.44–5.16)	0.52
Black Race	0.34(0.10–1.17)	0.09
eGFR	0.99(0.98–1.02)	0.77
AKI	3.74(1.50–9.30)	0.005
BMI	0.92(0.84–1.00)	0.06
Diabetes	2.47(0.99–6.15)	0.051
CHF	0.42(0.12–1.44)	0.17
Hypertension	0.89(0.36–2.21)	0.80
Cardiogenic Shock	0.96(0.37–2.54)	0.95
Cerebrovascular Disease	2.25(0.75–6.79)	0.15
Perfusion Time	1.01(1.00–1.02)	<0.001
Hematocrit	1.00(0.92–1.10)	0.87
Intraoperative PRBC use	3.42(1.13–10.32)	0.03
Rt. Atrial pressure	0.98 (0.90–1.07)	0.70
PCWP	1.02(0.97–1.13)	0.49
Cardiac Output	1.04 (0.74–1.45)	0.81
MULTIVARIATE ANALYSIS
Age	1.01(0.97–1.07)	0.56
Black Race	0.50(0.13–1.99)	0.33
AKI	3.01(1.15–7.91)	0.03
BMI	0.92(0.84–1.00)	0.07
Diabetes	2.76(0.98–7.72)	0.054
Perfusion Time	1.01(1.001–1.02)	0.02
Intraoperative PRBC use	2.34(0.75–7.31)	0.14

eGFR – estimated glomerular filtration rate

PRBC- Packed red blood cells

PVD- Peripheral vascular disease

CVD- Cerebrovascular disease

CHF- Congestive heart failure

BMI- Body Mass Index

PCWP- Pulmonary capillary wedge pressure